Atul Butte, head of systems medicine at Stanford University School of Medicine in California, is inclined to grant Hood the benefit of the doubt. He says that an innovative study of this kind might indeed pick up the earliest hints of disease: “They may not end up proving that all these individuals benefit from the study in one particular way, but they may end up showing that all these individuals benefit from the study in their own individual ways.”